1Norris SL, Zhang X, Avenell A, et al. Long - term non - pharmacologic weight loss intervention for adults with type 2 diabetes. Cochrabe Database Syst Rev 2000;1:57 -59.
2Klein S. Allison DB. Heymsfield SB et al. Waist circumfer- ence and cardiometabolic risk: a consensus statement from shaping A- merica' s health: Association for Weight Management and Obesity pre- vention; NAASO, the Obesity Society; the American Society for Nu- trition; and the American Diabetes Association . Diabetes Care 2007 ;30:1647 - 1652.
3Lloret - Linares C, Greenfield JR, Czemichow S. Effect of weight - reducing agents on glycaemic parameters and progression to type 2 diabetes: a review. Diabet Med 2008 ;25 : 1142 - 1150.
4Wing RR, Marcus MD, Epstein LH, et al. Type 2 diabetic sub- jects lose less weight than their overweight nondiabetic spouses. Diabe- tes Care 1987;10:563 -566.
5Pi - Sunyer FX. Weight loss in type 2 diabetic patients. Diabe- tes Care 2005 ;28:1526 - 1527.
6Malone . M. Medications associated with weight gain. Ann pharmacother 2005 ;39:2046 - 2055.
7Brown SA, Upchurch S, Anding R, et al. Promoting weight loss in type 2 diabetes. Diabetes Care 1996; 19:613 -624.
8Turner Re,Cull CA ,Frighi V, et al. for the UKPDS Group. Glycemic control with diets, sulfonylurea, metfotmin,or insulin in pa- tients with type 2 diabetes mellims. JAMA 1999;281:2005 -2012.
9Roubino F, Kaplan LM, Schauer PR, et al. on behalf of the Di- abetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes meUitus. Ann Surg 2010;251:399 -405.
同被引文献13
1Baysit E, Chapman RH, Grandy S. The relationship of body mass in dex to diabetes mellitus, hyperten sion and dyslipidaemia:com- parison of data from two national sarveys. In J clin praet 2007 ;61(5): 737 - 747.
2Wright A, Burders AC, Paisey RB, et al. for the UK Prospe- etive Diabetes study Group. sulfonylurca inadeguacy; Efficacy of addi- tion of insulin over 6 years in patients with type z dia be tes in the UK Prospective Diabetes Study ( UKPOS57 ). Diadetes Case 2002 ; 25 : 330 - 336.
4Rosenstock J, klaffl J, Schwartz S, et al. Effects exenatide and lifestyle modification on body weight and glucosp tolerancein obese subjects with and without pre-diabetes. Diabetos Cora 2010;33: 1173 - 1175.
